A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia
Sign Up to like & getrecommendations! Published in 2019 at "Nature biomedical engineering"
DOI: 10.1038/s41551-019-0387-2
Abstract: Acute myelogenous leukaemia (AML) is associated with risk factors that are largely unknown and with a heterogeneous response to treatment. Here, we provide a comprehensive quantitative understanding of AML proteomic heterogeneities and hallmarks by using… read more here.
Keywords: myelogenous leukaemia; heterogeneities hallmarks; analysis; leukaemia cell ... See more keywords
A novel canine B‐cell leukaemia cell line. Establishment, characterisation and sensitivity to chemotherapeutics
Sign Up to like & getrecommendations! Published in 2017 at "Veterinary and Comparative Oncology"
DOI: 10.1111/vco.12257
Abstract: We established a new B-cell leukaemia cell line CLB70 from a dog with chronic lymphocytic leukaemia. This cell line is positive for CD20, CD45, CD79a, MHC class II, IgG, IgM; weakly positive for CD21; and… read more here.
Keywords: cell line; cell leukaemia; line; leukaemia cell ... See more keywords
Caracasine, an ent-kaurane diterpene with proapoptotic and pro-differentiator activity in human leukaemia cell lines.
Sign Up to like & getrecommendations! Published in 2022 at "Anti-cancer agents in medicinal chemistry"
DOI: 10.2174/1871520622666220415105615
Abstract: BACKGROUND Kaurane-type diterpenoids, obtained from various natural sources, have shown many biological activities, including anti-inflammatory and antitumor effects. Caracasine (Fig 1), an ent-kaurane diterpenoid isolated from the flowers of Croton micans, was shown to induce… read more here.
Keywords: cell; jurkat; kaurane; leukaemia cell ... See more keywords